Published in J Steroid Biochem Mol Biol on November 22, 2009
Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative. Neurology (2012) 1.68
Physiological consequences of membrane-initiated estrogen signaling in the brain. Front Biosci (Landmark Ed) (2011) 1.18
Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol (2011) 1.03
Interactive effects of estrogen and serotonin on brain activation during working memory and affective processing in menopausal women. Psychoneuroendocrinology (2011) 0.94
Hormonal environment affects cognition independent of age during the menopause transition. J Clin Endocrinol Metab (2012) 0.92
Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women. Neuroimage (2012) 0.89
An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms. Brain Res (2013) 0.89
Alcohol effects on cognitive change in middle-aged and older adults. Aging Ment Health (2012) 0.88
Window of opportunity: estrogen as a treatment for ischemic stroke. Brain Res (2013) 0.88
Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Am J Geriatr Psychiatry (2011) 0.87
Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. Brain Imaging Behav (2014) 0.87
Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women. Neuropsychopharmacology (2013) 0.85
Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PLoS One (2014) 0.84
Donepezil plus estradiol treatment enhances learning and delay-dependent memory performance by young ovariectomized rats with partial loss of septal cholinergic neurons. Horm Behav (2011) 0.82
Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease. Epidemiol Rev (2013) 0.81
Estrogen-cholinergic interactions: Implications for cognitive aging. Horm Behav (2015) 0.80
ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA. Neurology (2013) 0.79
Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERα in female rat brain. Age (Dordr) (2012) 0.78
Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity. J Clin Endocrinol Metab (2011) 0.78
The GABAA antagonist bicuculline attenuates progesterone-induced memory impairments in middle-aged ovariectomized rats. Front Aging Neurosci (2015) 0.77
Modeling menopause: The utility of rodents in translational behavioral endocrinology research. Maturitas (2016) 0.76
Trajectories and phenotypes with estrogen exposures across the lifespan: What does Goldilocks have to do with it? Horm Behav (2015) 0.76
MPA: medroxy-progesterone acetate contributes to much poor advice for women. Endocrinology (2011) 0.76
How basic scientists help the pharmaceutical industry market drugs. PLoS Biol (2013) 0.76
Memory Decline in Peri- and Post-menopausal Women: The Potential of Mind-Body Medicine to Improve Cognitive Performance. Integr Med Insights (2014) 0.75
Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease. Am J Geriatr Psychiatry (2015) 0.75
Estrogen deficiency is associated with hippocampal morphological remodeling of early postmenopausal mice. Oncotarget (2017) 0.75
Voluntary exercise impairs initial delayed spatial alternation performance in estradiol treated ovariectomized middle-aged rats. Horm Behav (2013) 0.75
Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology (2015) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials (1998) 20.39
The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry (1987) 19.45
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging (2002) 12.71
The Women's Health Initiative recruitment methods and results. Ann Epidemiol (2003) 8.42
Implementation of the Women's Health Initiative study design. Ann Epidemiol (2003) 7.30
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26
Pathogenesis of leukoaraiosis: a review. Stroke (1997) 4.95
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
An image-processing system for qualitative and quantitative volumetric analysis of brain images. J Comput Assist Tomogr (1998) 3.49
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology (2006) 3.22
A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR Am J Neuroradiol (1994) 3.07
Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology (2009) 2.45
Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA (2001) 2.32
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol (2002) 2.27
Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol (1990) 2.18
Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol (1994) 2.14
The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials (1998) 2.09
Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology (1992) 2.05
Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab (2006) 2.03
Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology (1988) 1.99
"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab (1996) 1.98
Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology (2000) 1.85
Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc (1999) 1.73
Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med (1996) 1.57
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials (2004) 1.52
Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol (1994) 1.50
Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc (1996) 1.49
Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol (1990) 1.49
Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol (1999) 1.48
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging (2000) 1.43
Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol (1994) 1.41
The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience (2000) 1.41
Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke (1997) 1.33
Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology (2009) 1.32
Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology (1999) 1.31
Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology (2000) 1.29
Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology (1992) 1.28
Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav (1998) 1.27
Automatic segmentation of different-sized white matter lesions by voxel probability estimation. Med Image Anal (2004) 1.25
Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI). Acad Radiol (2007) 1.22
Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol (1994) 1.16
Estrogen replacement therapy and cognitive function in older women. JAMA (1993) 1.16
Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab (2009) 1.13
Cognitive function in nondemented older women who took estrogen after menopause. Neurology (1998) 1.07
Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol (1995) 1.07
Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology (1998) 1.00
The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. Maturitas (2000) 0.93
Learning and recall in subjects at genetic risk for Alzheimer's disease. J Neuropsychiatry Clin Neurosci (2002) 0.83
The role of estrogen in the treatment and prevention of dementia: introduction. Am J Med (1997) 0.82
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83
Hearing loss and incident dementia. Arch Neurol (2011) 4.65
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2007) 3.61
Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging (2006) 3.26
Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2008) 3.21
Morphological classification of brains via high-dimensional shape transformations and machine learning methods. Neuroimage (2004) 3.13
Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage (2008) 2.93
Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke (2007) 2.75
Simple paradigm for extra-cerebral tissue removal: algorithm and analysis. Neuroimage (2011) 2.69
Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol (2006) 2.68
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA (2009) 2.59
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob (2006) 2.55
Hearing loss and cognition in the Baltimore Longitudinal Study of Aging. Neuropsychology (2011) 2.54
The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2009) 2.53
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med (2013) 2.38
Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative. J Am Geriatr Soc (2012) 2.30
The Lifestyle Interventions and Independence for Elders Study: design and methods. J Gerontol A Biol Sci Med Sci (2011) 2.26
Hormone therapy and risk of Alzheimer disease: a critical time. JAMA (2002) 2.16
Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol (2003) 2.12
Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol (2008) 2.10
Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess (2003) 2.10
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain (2009) 2.05
Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain (2010) 2.04
Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab (2006) 2.03
Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly. Obes Res (2002) 1.89
Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps. Gastroenterology (2003) 1.88
Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol (2012) 1.85
Do weight loss and adherence cluster within behavioral treatment groups? Obesity (Silver Spring) (2013) 1.83
Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Am J Epidemiol (2005) 1.83
Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA (2003) 1.81
NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements (2013) 1.81
Using network science to evaluate exercise-associated brain changes in older adults. Front Aging Neurosci (2010) 1.79
Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study. J Am Geriatr Soc (2011) 1.76
Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol (2005) 1.74
Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis (2010) 1.73
Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis (2003) 1.72
Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab (2002) 1.70
Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Neuroimage (2007) 1.67
Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol (2006) 1.66
Differential association of concurrent, baseline, and average depressive symptoms with cognitive decline in older adults. Am J Geriatr Psychiatry (2008) 1.63
A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes. Menopause (2008) 1.60
Intima-media thickness and regional cerebral blood flow in older adults. Stroke (2009) 1.56
The effect of intentional weight loss on all-cause mortality in older adults: results of a randomized controlled weight-loss trial. Am J Clin Nutr (2011) 1.54
Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene. J Clin Oncol (2009) 1.54
Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess (2003) 1.52
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2007) 1.52
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials (2004) 1.52
Measuring size and shape of the hippocampus in MR images using a deformable shape model. Neuroimage (2002) 1.50
Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study. J Psychiatry Neurosci (2009) 1.49
Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol (2008) 1.49
Longitudinal changes in cortical thickness associated with normal aging. Neuroimage (2010) 1.49
UV light abuse as a substance-related disorder: clinical implications. Arch Dermatol (2008) 1.48
Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol (2006) 1.47
Effects of age on virtual environment place navigation and allocentric cognitive mapping. Behav Neurosci (2002) 1.47
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y). Brain Res (2013) 1.44
Cross-sectional and longitudinal analyses of anatomical sulcal changes associated with aging. Cereb Cortex (2005) 1.43
Cortical surface segmentation and mapping. Neuroimage (2004) 1.42
Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods. Contemp Clin Trials (2009) 1.41
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol (2011) 1.40
Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol (2006) 1.40
Preventing cognitive decline in usual aging. Arch Intern Med (2006) 1.38
Longitudinal changes in verbal memory in older adults: distinguishing the effects of age from repeat testing. Neurology (2003) 1.38
Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol (2004) 1.35
Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging (2007) 1.34
Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol (2010) 1.32
Longitudinal patterns of β-amyloid deposition in nondemented older adults. Arch Neurol (2011) 1.32
Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage (2011) 1.30
APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol (2010) 1.30
The Intensive Diet and Exercise for Arthritis (IDEA) trial: design and rationale. BMC Musculoskelet Disord (2009) 1.29